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Summary A prospective study of 232 patients with primary invasive breast cancer (UICC Stages I, II and III) and histologically confirmed axillary node status was carried out to assess the prognostic significance of several readily available clinical and pathological characteristics. In addition to the recognised utility of
tumour size and axillary lymph node status, the presence or absence of cohesive clumps of malignant cells in peritumoral vascular spaces (both lymphatic and blood vessels) was found to be prognostically important.
The overall survival rate in breast cancer has not
improved over the last few decades, despite better
radiotherapy techniques and a wide range of new
hormonal and cytotoxic agents (Brinkley et al.,
1984; Powles et al., 1980). It is accepted that a
proportion of cases with so called "localised"
mammary carcinomas have systemic disease at the
time of initial presentation which currently
available physical and biochemical methods fail to
detect. It is, therefore, important to have reliable
ways of identifying those patients most at risk of
developing metastatic disease who might
consequently benefit by receiving systemic adjuvant
therapy following primary surgical care. In the
absence of a single reliable prognostic criterion,
varying combinations of parameters may be used
(Fisher et al., 1975; Report of the Primary Therapy
of Breast Cancer Study Groups, 1978; Hutter, 1980;
Rosen et al., 1982). These include the size of the
primary tumour, its histological features and
oestrogen receptor content, the degree of elastosis
and small round cell infiltration, and most
important of all, axillary lymph node involvement
determined pathologically. However, these are far
from adequate so that there is still a need for other
prognostic indices.
Using recurrence rate (disease-free survival) as
the end point, we have found that the presence of
tumour emboli in vascular spaces associated with
primary breast cancer carries a bad prognosis
comparable in status to axillary lymph node
involvement.
Patients
A total of 232 consecutive patients with UICC
Stage I, II or III invasive breast carcinomas were
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Table I. Patient and pathological data of the 232
patients in the series.
No. ofpatients
Age (years)
mean
range
Menopausal status
pre-
peri-
post-
Tumour site
left
right
bilateral
Tumour size (cm)
mean
range
3 and <3
>3
Surgery
local excision with axillary biopsy
mastectomy with axillary clearance
Histology (all inflitrating carcinomas)
ductal
lobular
papillary
mucinous
medullary
232
57.9
27-88
50
17
165
119
109
4
2.7
0.4-12.0
176
56
29
203
223
4
1
3
1
entered into the study carried out at the Royal Marsden Hospital (Surrey Branch), St Helier, Crawley and Redhill General Hospitals between
September 1976 and March 1980. The mean follow-
up period is 64.5 months, (range, 45-84 months). The mean age of the patients is 57.9 years (range, 27-88 years). Seventy-one percent of the patients
were post-menopausal (at least 1 year after their
last menstrual period), 21% were menstruating
regularly and 8% were showing signs of "incipient'
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menopause at the time of presentation (peri-
menopausal) (Table I).
All patients had a blood sample taken and the
ESR, carcinoembryonic antigen, alkaline phos-
phatase and gamma-glutamyl transpeptidase levels
were measured. Only patients admitted to the
Royal Marsden Hospital and St. Helier Hospital
had a liver ultrasound, Technetium-99 bone scan
and skeletal survey as part of the pre-operative
investigations.
All patients had their primary tumours removed
surgically and the ipsilateral axillae explored. The
extent of surgical treatment ranged from local
excision with axillary biopsy to modified radical
mastectomy. The majority of patients were treated
by simple mastectomy with lower axillary clearance
(Table I). All patients with medial and/or central
primary tumours (regardless of axillary status) and
patients with pathologically confirmed axillary
nodal involvement, received post-operative
radiotherapy. The progress of all patients was
monitored on an out-patient basis: quarterly in the
first post-operative year, biannually for the next 2
years and thereafter annually. Both local
recurrences and the detection of distant metastases
were considered treatment failures (Karabali-
Dalamaga et al., 1978; Meir et al., 1980).
Methods
All the material was examined immediately after
operation. The tumour(s) were measured and
samples with a generous portion of surrounding
breast tissue taken. In addition, the nipple and
mammary tissue from each quadrant distant from
the main mass were examined. The axillae were
dissected and each lymph node taken for histology.
All the tissues were fixed in neutral buffered
formalin and processed for light microscopy and
staining with H and E by conventional methods.
Between one and three sections from each tumour
and one section of each lymph node were
examined. Steroid receptor analyses were not
available at the outset of this study.
In some instances, immunocytochemical methods
were used to outline vascular and lymphatic
channels (Bettelheim et al., 1983). The Logrank test
as described by Peto et al. (1977) was used for all
statistical analyses.
Histology
The pathological types of the 232 primary tumours
examined are shown in Table I. Of the ductal
carcinomas, 140 were of grade 2 and 83 of grade 3
(Bloom & Richardson, 1957). None was considered
to be of Grade 1. Interestingly, in this study,
lobular carcinomas were less frequent than would
have been expected (Fisher et al., 1975). Other
pathological features noted were the presence or
absence of tumour cells in vascular structures in
proximity to the dominant mass, desmoplasia, small
round cell infiltration, the presence or absence of
micro-calcification, the presence or absence of
elastosis, the number of lymph nodes involved with
tumour and the extent of such involvement:
minimal (single clump of malignant cells); <1/3 of
the lymph node mass as seen on the histological
section; > 1/3 of the lymph node; extention through
the nodal capsule. In cases with multiple nodal
metastases showing various extent of involvement
only the most extensive was charted.
Results
The patient data with potential prognostic
significance were submitted to multiparametric
analysis. The parameters were assessed singly and
in combination for disease-free survival. Clinical
factors such as age, menopausal status, tumour
side, or site were found not to be significant, as was
the type of surgical intervention, i.e. local excision
with axillary sampling as opposed to mastectomy
with axillary exploration (Table II). Overall of 29
patients subjected to local excision and axillary
sampling, 14 (48%) developed recurrences, while of
the 203 who had a mastectomy 82 (40%) developed
recurrences. However, 11/29 (38%) patients with
axillary sampling had involved nodes; 112/203
(55%) patients who had a mastectomy with axillary
clearance were found to have nodal involvement.
Tumour-associated substances (ESR, carcino-
embryonic antigen, alkaline phosphatase and
gamma-glutamyl transpeptidase) measured pre-
operatively did not help to identify the patients
likely to develop recurrent disease (Lawrence &
Neville 1983). Pathological data such as histological
tumour grade (Bloom & Richardson, 1957),
desmoplasia, elastosis, small round cell infiltration
and the presence or absence of tumour
microcalcification were not reflected in the disease
free survival. Three pathological factors, however,
were shown to be of prognostic value: tumour size,
axillary lymph node involvement and the presence
of cohesive clumps of tumour cells in peritumoral
vascular spaces (Bettleheim et al., 1983; Bettelheim
& Neville, 1981). The statistical results are shown in
Figures 1, 2 and 3 and Table II.
The disease-free survival in patients presenting
with tumours measuring <3cm was significantly
better compared to those whose tumours were
>3cm in their longest axis (chi-square=4.13;
P<0.05).PERITUMORAL VASCULAR INVASION AND PROGNOSIS 773
Table II. Incidence of lymph node metastases as a function of operative
procedure and resulting outcome.
Local excisiona Mastectomya
No. of No. of
Prognostic No. of recurrences No. of recurrences
factors patients (%) patients (%)
Lymph node -ve 18 (38.8) 91 (24)
(LN) +ve 11 (63.6) 112 (53.5)
Vascular invasion -ve 14 (42.8) 102 (27.4)
(VI) +ve 15 (53.3) 101 (53.4)
LN- VI- 9 (33.3) 65 (18.4)
LN- VI+ 9 (44) 26 (38.4)
LN+ VI- 5 (60) 37 (43)
LN+ VI+ 6 (66) 75 (58.6)
aI1/29 (38%) of patients with axillary sampling had lymph node involvement
while 112/203 (55%) with axillary clearance had involved nodes.
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Figure 1 Disease free survival by tumour size: ------ tumours measuring 3cm and <3cm (176 cases);
tumours measuring >3cm (56 cases). The difference in disease free survival is significant (chi
square
=4.13; P<0.05).
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Figure 2 Disease free survival by axillary lymph node status: axillary lymph nodes free of
tumour (117 cases); ------ axillary lymph nodes involved with tumour (115 cases). The difference in disease
free survival is significant (chi square=21,74; P<0.005).
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Figure 3 Disease free survival by vascular invasion: ------ no tumour cells identified in peritumoral
lymphatic and blood vessels (117 cases); tumour emboli seen in peritumoral vascular spaces
(115 cases). The difference in disease free survival is significant (chi-square 20.98; P<0.005).
lor)nn I %no-
L--
3
-,L
--L -- 11-1PERITUMORAL VASCULAR INVASION AND PROGNOSIS 775
Axillary lymph node involvement in breast cancer
irrespective of degree (Table II), was associated
with a recurrence rate of 54.4% in contrast to
26.8% in cases with negative axillary lymph nodes.
The difference in disease-free survival between
axillary lymph node positive and axillary lymph
node negative patients was statistically significant
(chi-square=20.26, P<0.005). There were only 7
cases of local recurrence without distant metastases
in this study and all occurred in patients whose
axillary nodes were uninvolved. No relation to the
type of surgical procedure was apparent: Five
patients were treated by a mastectomy, 2 had their
tumours removed locally.
The invasion by tumour cells of the vascular
structures in proximity to the primary lesion was of
similar significance with a recurrence rate of 53.4%
when used as a separate criterion. The recurrence
rate in tumours where vascular invasion was not
detected was 29.5%. The difference in disease-free
survival between these two groups was found to be
significant (chi-square=20.98; P<0.005). When
vascular invasion was adjusted for both tumour size
and axillary status, it retained its prognostic
significance (chi-square 9.2, P<0.01).
By combining axillary nodal status with vascular
invasion we were able to show that peritumoral
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vascular invasion identified in patients with axillary
lymph nodes free of tumour is a significant
prognostic factor (chi-square 9.85, P<0.005). In
patients with axillary lymph nodes involved with
tumour, however, the situation is less clear-cut: the
contrast between cases with peritumoral vascular
invasion present and cases where peritumoral
vascular invasion was absent, approached but did
not quite achieve significance at the 5% level with
chi-square=3.68 (Figures 4 and 5).
Discussion
There is a need to refine and identify further
factors which assist in the prognostic assessment of
patients with breast cancer. Moreover, the
identification of indices which are available to all
surgeons and pathologists would be of particular
value as not everyone has access to steroid receptor
analyses, esoteric screening methods, studies of
tumour ploidy, etc. Our study has confirmed the
Validity of tumour size and axillary nodal status
while drawing attention to the further prognostic
importance of the presence of tumour cells in
endothelial-lined spaces - both lymphatic channels
Time since surgery (years)
Figure 4 Disease free survival in axillary lymph node negative patients by vascular invasion: ------ no
tumour cells identified in peritumoral vascular spaces (76 cases); tumour emboli seen in
vascular spaces (41 cases). The difference in disease free survival is significant (chi-square 9.85; P<0.005).
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Figure 5 Disease free survival in axillary lymph node positive patients by vascular invasion: ------ no
tumour cells present in peritumoral vascular spaces (41 cases); tumour emboli present in
vascular spaces. The difference in disease free survival is not significant (chi-square 3.68; P<0.01).
and small blood vessels - closely associated with
primary invasive mammary carcinoma. This matter
has so far received only scant attention (Bettelheim
et al., 1983; Bettelheim & Neville, 1981; Kister et
al., 1966; Nime et al., 1977; Roberts & Hahnel,
1981; Rosen et al., 1981, 1982). Routine H & E
histological preparations are quite adequate for the
detection of vascular invasion by malignant cells
provided a generous stromal edge to the tumour is
taken (Bettelheim, et al., 1983). Our previous study
employed immunocytochemistry and various
antibodies to outline vascular and lymphatic
channels. This approach, although aesthetically
pleasing, did not increase the detection rate of such
intravascular tumour emboli. It did, however,
identify some small blood vessels interpreted as
lymphatic channels on routine preparations stained
by H & E (Report of the Primary Therapy of
Breast Cancer Study Groups, 1978).
In this study with a median follow-up of around
5 years, the invasion by tumour cells of lymphatic
and blood vessels associated with the primary
tumour, provided prognostic information equal to
that derived from axillary lymph node involvement.
A recurrence rate of 40% in the group of patients
with no axillary involvement but with intratumoral
vascular invasion contrasts with the 20.5%
recurrence rate from patients in whom neither
nodal nor vascular invasion was observed. The
assessment of vascular invasion, therefore, provides
important additional information in cases where
axillary lymph nodes are available for histological
examination. It is likely to become even more
valuable as a further prognostic parameter as more
and more surgeons practice local excisions without
axillary exploration for breast cancer.
In another separate, but related study, we have
found the presence of tumour cells in the bone
marrow in about 26% of patients at the time of
their initial presentation with breast cancer and
when all other diagnostic procedures failed to
reveal evidence of metastases (Sloane et al., 1980).
Preliminary analyses have shown a relationship
between the presence of such marrow
micrometastases and peritumoral vascular and/or
lymphatic invasion (Dearnaley et al., 1981; Redding
et al., 1983). Accordingly the finding of such inva-
sion may present an important feature for the strati-
fication of patients entering therapy trials and may
indicate the need for active adjuvant intervention.
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